These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 18640494)
1. Identification of parameters required for efficient lentiviral vector transduction and engraftment of human cord blood CD34(+) NOD/SCID-repopulating cells. Liu Y; Hangoc G; Campbell TB; Goodman M; Tao W; Pollok K; Srour EF; Broxmeyer HE Exp Hematol; 2008 Aug; 36(8):947-56. PubMed ID: 18640494 [TBL] [Abstract][Full Text] [Related]
2. Lentiviral gene transfer and ex vivo expansion of human primitive stem cells capable of primary, secondary, and tertiary multilineage repopulation in NOD/SCID mice. Nonobese diabetic/severe combined immunodeficient. Piacibello W; Bruno S; Sanavio F; Droetto S; Gunetti M; Ailles L; Santoni de Sio F; Viale A; Gammaitoni L; Lombardo A; Naldini L; Aglietta M Blood; 2002 Dec; 100(13):4391-400. PubMed ID: 12453876 [TBL] [Abstract][Full Text] [Related]
3. Delayed engraftment of nonobese diabetic/severe combined immunodeficient mice transplanted with ex vivo-expanded human CD34(+) cord blood cells. Guenechea G; Segovia JC; Albella B; Lamana M; Ramírez M; Regidor C; Fernández MN; Bueren JA Blood; 1999 Feb; 93(3):1097-105. PubMed ID: 9920860 [TBL] [Abstract][Full Text] [Related]
4. Transduction of human CD34+ CD38- bone marrow and cord blood-derived SCID-repopulating cells with third-generation lentiviral vectors. Guenechea G; Gan OI; Inamitsu T; Dorrell C; Pereira DS; Kelly M; Naldini L; Dick JE Mol Ther; 2000 Jun; 1(6):566-73. PubMed ID: 10933981 [TBL] [Abstract][Full Text] [Related]
5. Transduction of human hematopoietic stem cells by lentiviral vectors pseudotyped with the RD114-TR chimeric envelope glycoprotein. Di Nunzio F; Piovani B; Cosset FL; Mavilio F; Stornaiuolo A Hum Gene Ther; 2007 Sep; 18(9):811-20. PubMed ID: 17824830 [TBL] [Abstract][Full Text] [Related]
6. Lentiviral gene transfer into primary and secondary NOD/SCID repopulating cells. Woods NB; Fahlman C; Mikkola H; Hamaguchi I; Olsson K; Zufferey R; Jacobsen SE; Trono D; Karlsson S Blood; 2000 Dec; 96(12):3725-33. PubMed ID: 11090053 [TBL] [Abstract][Full Text] [Related]
7. Efficient oncoretroviral transduction of extended long-term culture-initiating cells and NOD/SCID repopulating cells: enhanced reconstitution with gene-marked cells through an ex vivo expansion approach. Björgvinsdóttir H; Bryder D; Sitnicka E; Ramsfjell V; De Jong I; Olsson K; Rusterholz C; Karlsson S; Jacobsen SE Hum Gene Ther; 2002 Jun; 13(9):1061-73. PubMed ID: 12067439 [TBL] [Abstract][Full Text] [Related]
8. Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34(+) cord blood cells after ex vivo expansion: evidence for the amplification and self-renewal of repopulating stem cells. Piacibello W; Sanavio F; Severino A; Danè A; Gammaitoni L; Fagioli F; Perissinotto E; Cavalloni G; Kollet O; Lapidot T; Aglietta M Blood; 1999 Jun; 93(11):3736-49. PubMed ID: 10339480 [TBL] [Abstract][Full Text] [Related]
9. Highly efficient transduction of the green fluorescent protein gene in human umbilical cord blood stem cells capable of cobblestone formation in long-term cultures and multilineage engraftment of immunodeficient mice. van Hennik PB; Verstegen MM; Bierhuizen MF; Limón A; Wognum AW; Cancelas JA; Barquinero J; Ploemacher RE; Wagemaker G Blood; 1998 Dec; 92(11):4013-22. PubMed ID: 9834203 [TBL] [Abstract][Full Text] [Related]
10. Preclinical ex vivo expansion of cord blood hematopoietic stem and progenitor cells: duration of culture; the media, serum supplements, and growth factors used; and engraftment in NOD/SCID mice. Lam AC; Li K; Zhang XB; Li CK; Fok TF; Chang AM; James AE; Tsang KS; Yuen PM Transfusion; 2001 Dec; 41(12):1567-76. PubMed ID: 11778074 [TBL] [Abstract][Full Text] [Related]
11. Comparison of three retroviral vector systems for transduction of nonobese diabetic/severe combined immunodeficiency mice repopulating human CD34+ cord blood cells. Leurs C; Jansen M; Pollok KE; Heinkelein M; Schmidt M; Wissler M; Lindemann D; Von Kalle C; Rethwilm A; Williams DA; Hanenberg H Hum Gene Ther; 2003 Apr; 14(6):509-19. PubMed ID: 12718762 [TBL] [Abstract][Full Text] [Related]
12. Long-term engraftment of nonobese diabetic/severe combined immunodeficient mice with human CD34+ cells transduced by a self-inactivating human immunodeficiency virus type 1 vector. Gatlin J; Padgett A; Melkus MW; Kelly PF; Garcia JV Hum Gene Ther; 2001 Jun; 12(9):1079-89. PubMed ID: 11399229 [TBL] [Abstract][Full Text] [Related]
13. High levels of transgene expression following transduction of long-term NOD/SCID-repopulating human cells with a modified lentiviral vector. Gao Z; Golob J; Tanavde VM; Civin CI; Hawley RG; Cheng L Stem Cells; 2001; 19(3):247-59. PubMed ID: 11359950 [TBL] [Abstract][Full Text] [Related]
14. Optimal conditions for lentiviral transduction of engrafting human CD34+ cells. Uchida N; Hsieh MM; Hayakawa J; Madison C; Washington KN; Tisdale JF Gene Ther; 2011 Nov; 18(11):1078-86. PubMed ID: 21544097 [TBL] [Abstract][Full Text] [Related]
15. Lentiviral vector transduction of NOD/SCID repopulating cells results in multiple vector integrations per transduced cell: risk of insertional mutagenesis. Woods NB; Muessig A; Schmidt M; Flygare J; Olsson K; Salmon P; Trono D; von Kalle C; Karlsson S Blood; 2003 Feb; 101(4):1284-9. PubMed ID: 12393514 [TBL] [Abstract][Full Text] [Related]